CPL is Advancing Topicals Through Scientifically Driven Semi-solid Development
By Kyle Loethen
CPL is Advancing Topicals Through Scientifically Driven Semi-solid Development
Lucy Zhao’s Mucoadhesive Study Named to Special Poster Collection at 2025 AAPS PharmSci360
By tn_admin
Chetan Chure Presents Advancements in Mucoadhesive Drug Delivery at 2025 AAPS PharmSci360
By tn_admin
CPL Appoints Joe Troxell as Chief Executive Officer
By tn_admin
Aterian Investment Partners Acquires Contract Pharmaceuticals Limited
By tn_admin
CPL Appoints Greg Tayler as Chief Financial Officer
By tn_admin
CPL Expands Capacity to Perform GMP <i>In Vitro</i> Permeation Testing (IVPT)
By tn_admin